Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Close this folder13. Partnership and collaboration
View the document13.1 The importance of supportive partners
View the document13.2 Possibilities at national, regional and international levels
Close this folder13.3 Various forms of collaboration
View the document13.3.1 Twinning arrangements
View the document13.3.2 Sharing information and resources
View the document13.3.3 Using established bulletins’ expertise
View the document13.3.4 Training sessions and workshops
View the document13.3.5 Ongoing information exchange between bulletins
View the document13.3.6 Collaborative research among bulletins
View the document13.3.7 Information and support for funding applications
View the document13.4 Identifying partners and networks
View the document13.5 Clearly define conditions for partnership
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information

13.3.6 Collaborative research among bulletins

Bulletins can collaborate for research. Box 13.2 contains examples of such collaborative work.

Box 13.2 Results of collaborative research among drug bulletins

• “Judging the therapeutic value of drugs: a comparison between la revue Prescrire and Information fran Lakemedelsverket, the bulletin of the Swedish Medical Products Agency” International Journal of Risk & Safety in Medicine 2004;16:83-90.

• “Prescribing information in 26 countries: a comparative study” Eur J Clin Pharmacol 2003; 59: 263-270. Collaborative study by WHO, Institut Català de Farmacologia, Istituto Mario Negri and ISDB.

• “An ISDB survey (23 bulletins) to assess the degree of transparency of drug regulatory agencies” International Journal of Risk & Safety in Medicine 1996;9:151-155.

• “An international survey of quality control procedures in independent drug bulletins” Poster 1996.

• “How informed general practitioners manage mild hypertension: a survey of readers of drug bulletins in 7 countries” Eur J Clin Pharmacol 1996;49:445-450.

• ISDB survey on “Which books are essential for bulletins?” by 15 bulletins, five of them in developing countries ISDB Newsletter July 1995.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017